These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 4427254)
81. In vitro-in vivo extrapolation method to predict human renal clearance of drugs. Kunze A; Huwyler J; Poller B; Gutmann H; Camenisch G J Pharm Sci; 2014 Mar; 103(3):994-1001. PubMed ID: 24549735 [TBL] [Abstract][Full Text] [Related]
82. Monitoring pediatric iv drugs. Smith SC; Crass RE Drug Intell Clin Pharm; 1984 Jun; 18(6):530-1. PubMed ID: 6734441 [No Abstract] [Full Text] [Related]
83. Drug bioavailability information and its utility. Chun AH; Seitz JA J Am Pharm Assoc; 1974 Aug; 14(8):407-14. PubMed ID: 4851441 [No Abstract] [Full Text] [Related]
84. Use of confidence intervals in analysis of comparative bioavailability trials. Westlake WJ J Pharm Sci; 1972 Aug; 61(8):1340-1. PubMed ID: 5050398 [No Abstract] [Full Text] [Related]
85. Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro. Barbhaiya RH; Gerber AU; Craig WA; Welling PG Antimicrob Agents Chemother; 1982 Mar; 21(3):472-80. PubMed ID: 7103450 [TBL] [Abstract][Full Text] [Related]
86. Measurement of the renal clearance of drugs. Tucker GT Br J Clin Pharmacol; 1981 Dec; 12(6):761-70. PubMed ID: 7041933 [No Abstract] [Full Text] [Related]
87. Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity. Lalka D; du Souich P; McLean AJ; Gibaldi M J Pharm Sci; 1978 Apr; 67(4):591-2. PubMed ID: 641784 [No Abstract] [Full Text] [Related]